The MarketWatch News Department was not involved in the creation of this content. SAS predicts the path for data and AI to reshape how the industry discovers, treats and delivers care CARY, N.C., Dec.

CROWN POINT, Ind. — OYE Therapeutics Inc., a privately held biopharmaceutical company developing first-in-class intravenous caffeine-based therapies for anesthesia recovery and opioid-induced ...

Virax Biolabs' (VRAX) proprietary in-development diagnostic technology for post-acute infection syndromes ("PAIS"), such as Long COVID, positions the Company for an important data year ahead, ...

Please provide your email address to receive an email when new articles are posted on . Black and Hispanic patients had a significantly lower likelihood of accessing their digital clinical notes.

Forbes contributors publish independent expert analyses and insights. Peter Cohan, a Boston-based senior contributor, covers stocks. This result seems to violate one of my basic rules of investing: ...

Despite “a few remaining points of disagreement,” President Trump heralded his team’s “tremendous progress” made towards ending Russia’s war in Ukraine. Earlier, his top diplomat, US Secretary of ...

Ukraine and its allies welcomed progress Monday after high-stakes talks with the United States over the plan to end Russia’s war, which Washington has pressured Kyiv to endorse by Thanksgiving.

AUSTIN, Texas, Nov. 24, 2025 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: As advanced biotech programs move closer to commercialization, fair-value adjustments under U.S. Generally Accepted ...

“The September jobs report more than doubled market expectations — adding 119,000 new jobs to the American economy. In stark contrast to the disastrous Biden economy, almost all of these new jobs were ...

Amy Nunn and Philip Chan had just started to enroll participants in a federally funded clinical trial for HIV prevention when their work came to an abrupt halt in early March. “I panicked,” said Nunn, ...

President Donald J. Trump inherited an economic mess when he took office. Years of mismanagement under Biden, his incompetent Administration, and Democrats in Congress — who spent years insisting ...